The first stage of trials of bird flue vaccine, developed in Russian veterinarian research institute of stock-raising, was successfully completed, reported the Institute chief executive Eduard Djavadov. The trials of dead vaccine against highly pathogenic virus of bird flue started in November. Protective antibody dilution was detected on the base of birds? blood research results. "After the New Year?s celebration we are going to draw up a statement of fact on the research result, and the vaccine will be passed for consideration to Department of Agriculture and to Academy of Agricultural science", Djavadov said. He also noted, that in case of vaccine approval, the trials with birds infection with H5N1 virus would be necessary. This kind of trials can be conducted in research institute of veterinary virology and microbiology in Pokrov town, it having all necessary conditions for operating with dangerous virus.
sections: Nature & Health, Region News regions: Central region |